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Introduction
Growth in the number of marketed dietary supplements 
has been marked, increasing from 4,000 products in 1994 to 
55,000 in 2009.1 Dietary supplements result in .$20 billion in 
sales each year with growth of about 6% per year2 and preva-
lence of dietary supplement use is common in the United States 
(US) general public.3,4 In national studies, among Hispanics/
Latinos, the reported prevalence of any dietary supplement use 
(34%) in the past 30 days was lower as compared with non-
Hispanic whites (59%).3 National studies of botanical and 
nonvitamin, nonmineral (NVNM) supplement use in the prior 
year also report lower prevalence among Hispanics/Latinos, 
12% compared with 23%,4 but other studies conducted within 
Hispanic/Latino populations have resulted in much higher 
estimates: .60% in the past 12 months,5,6 leading to questions 
about the comparability of these study designs.
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AbstrAct: Although dietary supplement use is common, its assessment is challenging, especially among ethnic minority populations such as Hispanics/
Latinos. Using the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) (n = 16,415), this report compares two strategies for capturing 
dietary supplement use over a 30-day period: a medication-based inventory and a nutrition-based dietary supplement interview. Age-standardized preva-
lence was calculated across multiple dietary supplement definitions, adjusted with survey/nonresponse weights. The prevalence of dietary supplement use 
was substantially higher as measured in the dietary supplement interview, compared to the medication inventory: for total dietary supplements (39% vs 26%, 
respectively), for nonvitamin, nonmineral supplements (24% vs 12%), and for botanicals (9.2% vs 4.5%). Concordance between the two assessments was fair 
to moderate (Cohen’s kappa: 0.31–0.52). Among women, inclusion of botanical teas increased the prevalence of botanical supplement use from 7% to 15%. 
Supplement assessment that includes queries about botanical teas yields more information about patient supplement use.
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Assessment of supplement use is challenging in any 
population, but is particularly difficult among ethnic minori-
ties and with regard to botanical and other NVNM supple-
ments. Most observational studies rely on self-completed 
questionnaires7–10 or telephone surveys11 to collect dietary 
supplement data, asking participants to choose from a list of 
supplements that may or may not be consistent with cultural 
traditions. Product examination is considered a criterion stan-
dard for supplement assessment,12 but, if not assessed in the 
home, could miss supplements individuals forget to bring in 
to the study visit. Moreover, disclosure of supplement use to 
healthcare providers has been suboptimal, potentially leaving 
patients open to adverse effects.13 A more systematic approach 
to supplement assessment is clearly indicated.
The current study utilizes the baseline data of the His-
panic Community Health Study/Study of Latinos (HCHS/
SOL). HCHS/SOL is unique in its supplement assessments 
in two ways. The study collected supplement data in a sam-
ple of US Hispanics/Latinos using both a dietary interview 
method and a medication-based (product examination inven-
tory) method to assess supplement use over 30 days. In addi-
tion, supplement use was also captured in the 24-hour dietary 
recall data, reflecting immediate use. This analysis catego-
rized dietary supplement types and measured their prevalence 
among Hispanics/Latinos of diverse Hispanic backgrounds 
by a medication inventory (MV) and a dietary supplement 
interview (DI). The analysis also addresses the prevalence of 
common supplement ingredients.
Methods
data source. The HCHS/SOL is a prospective cohort 
study designed to identify risk factors and disease prevalence 
among Hispanic/Latino residents of four communities in the 
US (Miami, Bronx, Chicago, and San Diego). To achieve a 
representative sample of the target population, a two-stage 
area household probability design was employed.14,15 HCHS/
SOL investigators chose communities to achieve a balanced 
recruitment of Hispanics/Latinos from across countries of 
origin and geographic areas of the US.14 Within communi-
ties, census tracts were selected based on their proximity to 
the field center clinics and demographics; study plans called 
for cross-stratifying by high vs low concentration of Hispanic/
Latino residents and high vs low SES.15 The recruitment plan 
focused on advertising and face-to-face recruitment within 
neighborhoods and housing blocks, including communities 
with high concentrations of Hispanics/Latinos.14,15 Hispanic/
Latino community involvement was key to the highly suc-
cessful recruitment strategy.15 This report is based on cross- 
sectional data from the baseline data collection, 2008–2011.
study population. The study enrolled 16,415 nonin-
stitutionalized adults who self-identified their background 
as Cuban, Dominican, Puerto Rican, Mexican, Central 
American, South American, or other Hispanic/Latino. Of 
the enrolled, 16,279 had data for the outcomes and were 
included in the analyses. Individuals within sampled house-
holds were screened for eligibility (living in the household, age 
18–74, able to attend a clinic visit, and not planning to move 
within six months).15 Enrolled individuals attended a com-
prehensive examination visit at the study field center where 
they reviewed/signed consent documents and participated in 
study assessments, including demographic, medical, nutri-
tion, and physical activity assessments. Study procedures were 
approved by human research ethics boards at participating 
institutions. Human research ethics approval for the  current 
study was waived by the University of North Carolina Institu-
tional Review Board, because the analysis was based solely on 
secondary, de-identified data.
categorization of the dietary supplement data. The 
medication inventory, the dietary supplement interview, and 
the two 24-hour dietary recalls all contained product name 
files for a variety of dietary supplements. Dietary supple-
ment products were categorized using an adapted form of 
the Langual categorization system proposed by Saldanha 
et al.16 The Langual system involves coding multiple fac-
ets of a product, from the general, to the specific. For this 
study, coded facets included product type (Facet A), physi-
cal form (Facet E, with collapsed categories), and ingredients 
(Facet H).
Although the Langual system nicely organizes dietary 
supplement ingredients, definitions of dietary supplement 
product types have not yet been standardized. In this study, 
based on the available product information, combination 
products that contained $50% of the recommended daily 
allowance (RDA) of a vitamin or mineral, and also contained 
a botanical or other NVNM ingredient were classified as a 
dietary supplement with NVNM. Those that contained ,50% 
RDA of a vitamin or mineral were classified as a primarily 
NVNM product. Botanicals were similarly classified. NVNM 
products included botanicals, but botanical products excluded 
other NVNM (eg, glucosamine, coenzyme Q10, omega-3 
and omega-6 fatty acids, fiber products, enzymes, probiotics, 
amino acids, and protein supplements) (Fig. 1). Based on these 
classifications, supplement users were defined as: (1) users of 
any dietary supplements; (2) users of supplements containing 
any NVNM (including botanicals); (3) users of supplements 
consisting of primarily NVNM ingredients (including botani-
cals); (4) users of supplements containing any botanical ingre-
dients; (5) users of primarily botanical supplements.
Measurement variables. Medication inventory. Partici-
pants in the HCHS/SOL were asked to bring all medications, 
dietary supplements, and herbal remedies taken in the four 
weeks prior to their baseline visit. The medication inventory 
was designed to therapeutically classify all prescription and 
over-the-counter medications and supplements, including 
vitamins, minerals, botanicals, and supplements used by par-
ticipants during the four weeks preceding examination. The 
inventory involved scanning any Universal Product Code bar 
code symbols on medication packaging, pill imprint searches 
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using Facts & Comparisons® Drug Identifier and Ident-A-Drug 
Reference © when necessary, and automated therapeutic clas-
sification of .99% of products based on their generic/brand 
name using a Master Drug Data Base (Medispan MDDB®) 
supplemented with Spanish-language brand and generic name 
equivalents from Lexi-Comp Online™ and OVID © Mar-
tindale. For the remaining 1% of products, manual coding was 
performed by healthcare professionals with expertise in medi-
cation and supplement identification. Approximately 10,000 
products were identified as dietary supplements. Over 1,600 
products could not be coded beyond identification as a dietary 
supplement because of insufficient information, resulting in 
missing NVNM data for 630 individuals (4%).
Dietary supplement interview. At the time of the field 
center clinic visit, immediately following the 24-hour dietary 
recall, technicians interviewed participants (in Spanish or 
English, according to their preference) about their recalled 
dietary supplement use in the 30 days prior to the study visit. 
The dietary supplements from the 30-day supplement inter-
view were recorded in the Dietary Supplement Assessment 
Module (DSAM) of the Nutrition Data System for Research 
database (NDSR). Information for supplements that did not 
match in the DSAM were updated from the product label 
(obtained from the manufacturer when possible) and validated 
against outside resources. DSAM-based product name files 
were recorded with greater detail than the medication inven-
tory files, enabling refined product coding. The dietary sup-
plement interview data consisted of ∼2,700 different products 
representing ∼15,000 entries. Calculations of the prevalence 
of individual botanicals within dietary supplement products 
depended on the DSAM ingredient-level dataset. Botanical 
supplement reports were limited to those with a prevalence of 
at least 0.2%.
Twenty-four-hour dietary recall. The 30-day dietary 
supplement interview files recorded a few botanical teas. 
However, botanical teas, other liquid dietary supplement 
products, and culturally specific botanicals appeared in the 
two 24-hour dietary recalls enabling the calculation of: 
(1) estimates of supplement use including botanical teas and 
(2) estimates also including green tea (Camellia sinensis) and 
nopal (whole fruit).
statistical analysis. The distribution of key variables 
was examined across dietary supplement users, NVNM 
supplement users, and botanical supplement users, including 
demographics (age, gender, education, percent of poverty for 
family size, and year), healthcare access (percent of poverty, 
insurance status, self-reported lack of access to care), health 
behaviors (cigarette smoking, diet quality, physical activity), 
and acculturation measures (language preference, years of 
residence in the US, born in US). All variables were examined 
Medication inventory
Use of dietary supplement products primarily
non-vitamin, non-mineral ingredients, including botanicals
Use of dietary supplement products
containing any botanicals
Use of dietary supplements
that are primarily
botanicals
n =
654
n =
1,084
n = 1,677n = 877
n = 2,013
n = 2,299
n = 3,409
n = 4,404
Use of dietary supplement products with any
non-vitamin, non-mineral ingredients, including botanicals
Use of any dietary supplement, including vitamins and minerals
n = 4,781 n = 6,930
Dietary supplement interview
figure 1. dietary supplement assessment protocol.
notes: sample is restricted to participants with data for both the medication inventory and the dietary supplement interview. For the medication 
inventory, participants were asked to bring in all dietary supplements and home remedies taken in the past four weeks. supplements were recorded in the 
medications database. For the dietary supplement interview, after providing information about food intakes in the past 24 hours, participants responded 
to a series of questions about their supplement use in the past 30 days. the dietary supplement interview utilized the dietary supplements assessment 
module of the Nutrition Data System for Research. Additional botanicals, captured with the 24-hour food recalls, are not reflected in the figure because of 
a differing time frame.
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for missing data; analyses were based on 16,060 individuals 
who had data for both the medication inventory and dietary 
supplement interview.
Because neither the dietary supplement interview nor the 
medication inventory could be considered a gold standard mea-
sure, comparison of the two was limited to calculation of Cohen’s 
kappa statistics with positive and negative agreements17 and 
prevalence and bias-corrected kappa (PABAK).18 Kappa statis-
tics were interpreted following established criteria.19 In addition, 
to look at the sensitivity of dietary supplement prevalence esti-
mates to various assumptions, estimates were calculated based 
on: (1) the dietary supplement interview updated with botanical 
teas from the 24-hour dietary recall; (2) the dietary supplement 
interview with 24-hour recall data, including nopal and green 
tea; and (3) the combined dietary supplement interview, medica-
tion inventory, and dietary recall.
table 1. distribution of sample population characteristics by the use of supplement typesa in hchs/sOL.
USeRS of AnY 
SUppLeMentSa 
n = 7,658
USeRS of 
AnY nvnM 
SUppLeMentS 
n = 3,916
USeRS of AnY 
botAnICAL 
SUppLeMentS 
n = 1,433
nonUSeRS  
of DIetARY  
SUppLeMentS 
n = 8,402
nb Mean or% 
(95% CI)c
Mean or% 
(95% CI)c
Mean or% 
(95% CI)c
Mean or%  
(95% CI)c
Mean age 16, 279 45.5 (44.8, 46.2) 46.4 (45.6, 47.1) 43.8 (42.8, 44.8) 37.7 (37.2, 38.2)
% Female 9,764 56.5 (54.7, 58.3) 54.8 (52.5, 57.1) 58.4 (55.0, 61.7) 48.3 (46.7, 49.8)
Mean% poverty threshold 14,669 169 (160, 178) 182 (170, 193) 183 (169, 197) 142 (137, 147)
Hispanic/Latino background (%)
 dominican 1,466 9.8 (8.3, 11.6) 7.6 (6.3, 9.3) 6.6 (5.2, 8.4) 9.8 (8.4, 11.3)
 central american 1,718 7.7 (6.5, 9.0) 8.3 (7.0, 10.0) 8.6 (6.9, 10.6) 7.0 (6.0, 8.2)
 cuban 2,338 18.7 (16.0, 21.7) 19.4 (16.6, 22.5) 16.1 (13.4, 19.3) 22.8 (19.1, 26.8)
 Mexican 6,455 40.0 (36.5, 43.6) 41.6 (37.8, 45.6) 46.9 (42.7, 51.2) 34.7 (31.5, 38.1)
 Puerto rican 2,708 14.6 (13.0, 16.3) 13.3 (11.5, 15.4) 12.6 (10.4, 15.2) 17.0 (15.2, 19.0)
 south american 1,071 5.6 (4.8, 6.5) 6.0 (5.0, 7.3) 5.6 (4.4, 7.2) 4.6 (4.0, 5.3)
 Other 523 3.7 (3.0, 4.6) 3.7 (2.8, 4.8) 3.6 (2.5, 5.1) 4.1 (3.5, 4.8)
Preference for spanish 13,009 74.8 (72.6, 76.8) 74.7 (72.2, 77.0) 75.5 (72.5, 78.1) 76.6 (74.4, 78.7)
Born in Us (%) 2,855 21.5 (19.6, 23.5) 20.7 (18.7, 22.8) 20.7 (18.1, 23.4) 21.5 (20.0, 23.1)
Mean years in Us 16,211 21.2 (20.5, 21.9) 21.1 (20.3, 21.9) 21.1 (20.2, 21.9) 20.0 (19.1, 20.8)
education (%)
 <hs 6,091 28.5 (26.5, 30.6) 25.8 (23.5, 28.3) 25.5 (22.5, 28.7) 36.2 (34.5, 38.1)
 hs graduate 4,116 26.3 (24.6, 28.0) 24.9 (22.8, 27.1) 23.7 (21.1, 26.5) 29.2 (27.8, 30.6)
 at least some college 5,741 45.2 (42.8, 47.7) 49.3 (46.3, 52.2) 50.8 (47.1, 54.5) 34.6 (32.9, 36.3)
% with no insurance 7,893 47.2 (44.8, 49.7) 50.0 (47.0, 53.0) 53.2 (49.4, 57.1) 50.6 (48.6, 52.7)
% unable to get needed healthcare 2,695 15.1 (13.7, 16.6) 15.6 (14.0, 17.4) 17.0 (14.8, 19.4) 15.6 (14.4, 16.8)
% meeting physical activity guidelinesd 10,335 68.7 (66.9, 70.5) 70.4 (68.3, 72.5) 71.3 (68.2, 74.2) 64.5 (63.1, 66.0)
Mean aheIe 16,126 48.3 (47.9, 48.7) 48.9 (48.4, 49.4) 49.5 (49.0, 50.1) 47.1 (46.7, 47.5)
Cigarette use (%)
 never smoked 9,884 64.6 (62.8, 66.4) 64.8 (62.4, 67.0) 63.0 (59.5, 66.3) 57.8 (56.0, 59.5)
 Former smoker 3,216 18.6 (17.3, 20.1) 19.8 (18.1, 21.6) 21.3 (18.9, 24.1) 17.6 (16.5, 18.7)
 current smoker 3,148 16.7 (15.1, 18.5) 15.5 (13.7, 17.4) 15.7 (13.2, 18.5) 24.7 (23.3, 26.1)
(Continued)
results
characteristics of the study population. Distributions 
of key characteristics of the study population are presented, 
classifying participants as users of any dietary supplement 
(n = 7,658), users of NVNM supplements (including botani-
cals) (n = 3,916), users of botanical supplements (n = 1,433), 
and users of no supplements (n = 8,402) based on their reported 
use in either the dietary supplement interview or the medica-
tion inventory (Table 1). Supplement use categories are nested 
(Fig. 1). Users of supplements that included NVNM ingredi-
ents were older (mean age of 46 vs 38 years among nonusers), 
more likely to be female (55 vs 48%), and more likely to be 
nonsmokers (65 vs 58%).
Users of botanical supplements only had a higher educa-
tion and greater adherence to a higher quality diet as mea-
sured by the 2010 Alternative Healthy Eating Index. They 
Assessing dietary supplement use in the Hispanic community
5IntegratIve MedIcIne InsIghts 2016:11
were more likely to be of Mexican background and living in 
San Diego; they were less likely to have insurance or to have 
access to needed healthcare.
concordance of the medication inventory and dietary 
supplement interview. Prevalence of supplement use as mea-
sured by the dietary supplement interview was higher than 
that for the medication inventory, even for overall dietary 
supplement use (39.3% vs 25.9%) (Table 2). The absolute dif-
ferences were smaller, but the proportional difference was 
greater for NVNM and botanical products: prevalence esti-
mates of products with any NVNM or botanical components 
in the dietary supplement interview were about twice that 
of the medication inventory. Positive agreement and overall 
kappa statistics were consistent with moderate agreement 
for most comparisons (κ : 0.44–0.52). Kappa for botanical 
products was only fair (κ : 0.31–0.36), but negative agree-
ment was high, as was prevalence and bias-adjusted kappa 
(PABAK: 0.81–0.88). Kappa statistics for liquid or powdered 
products (κ : 0.11–0.13) were low, but negative agreement for 
these products were high at 0.96–0.99 (PABAK: 0.85–0.95). 
In fact, negative agreement was high across all categories of 
supplements (κ : 0.82–0.99). In sensitivity analyses, assign-
ing uncategorized products from the medication inventory to 
NVNM or botanical supplements, based on their similarity 
to products that were definitely classified as such, reduced the 
disparity between the two assessments (Table 2).
sensitivity of the prevalence estimates to the mea-
surement strategy. NVNM and botanical prevalence esti-
mates were sensitive to inclusion of botanical teas and other 
liquid supplements captured in the dietary recalls (Fig. 2). 
The use of botanical teas (excluding green tea) was rela-
tively common: A total of 6.5% (95% CI: 5.8–7.3) reported 
a botanical tea or other botanical liquid product on either 
of the recall visits. The prevalence of use of any nopal was 
3.2% (95% CI: 2.7–3.6), and the prevalence of the use of 
dietary green tea was 3.6% (95% CI: 3.1–4.1). If teas, liquid 
nopal, and other liquid supplements were included in the 
estimates as primarily botanical supplements, prevalence 
increased by 131% in women and 105% in men. Addition-
ally, counting brewed green tea and nopal as botanical sup-
plements increased the prevalence of botanical supplements 
substantially, by 32% in women and 34% in men. Addition-
ally, counting all fiber products as botanicals increased the 
prevalence of botanical use by another 9% in women and 
11% in men to 22.5% and 14.7%, respectively. The combined 
dietary and medication information resulted in a prevalence 
of 43.6% (95% CI: 42.2–45.0) for any dietary supplement, 
27.8% (95% CI: 26.5–29.1) for supplements with NVNM, 
and 11.9% (95% CI: 11.0–12.7) for supplements with any 
botanical components.
Prevalence of individual supplement ingredients. 
NVNM ingredients included fish oil, glucosamine or related 
products, lutein-containing products; prevalence of these 
substances and individual botanical ingredients were calcu-
lated from the ingredient files (Table 3). Among the NVNM 
supplements, omega-3 fatty acids, lutein, and lycopene were 
the most common, occurring with a prevalence of about 10%. 
Omega-3 fatty acids were most often consumed as single 
table 1. (Continued)
USeRS of AnY 
SUppLeMentSa 
n = 7,658
USeRS of 
AnY nvnM 
SUppLeMentS 
n = 3,916
USeRS of AnY 
botAnICAL 
SUppLeMentS 
n = 1,433
nonUSeRS 
of DIetARY 
SUppLeMentS 
n = 8,402
nb Mean or% 
(95% CI)c
Mean or% 
(95% CI)c
Mean or% 
(95% CI)c
Mean or% 
(95% CI)c
Self-reported health (%)
 Fair-poor 4,834 25.5 (23.7, 27.4) 24.3 (22.2, 26.5) 23.7 (21.2 (26.5) 26.3 (25.0, 28.0)
 good 7,492 45.1 (43.1, 47.0) 44.1 (41.7, 46.5) 46.1 (43.0, 49.3) 46.8 (45.3, 48.4)
 very good–excellent 3,898 29.4 (27.5, 31.4) 31.6 (29.0, 34.3) 30.2 (27.0, 33.5) 26.6 (25.2, 28.1)
geographic area (US) (%)
 Bronx 4,051 25.8 (22.9, 28.9) 21.2 (18.5, 24.2) 18.1 (15.3, 21.3) 29.8 (26.6, 33.1)
 chicago 4,108 14.2 (12.3, 16.3) 14.6 (12.4, 17.1) 15.2 (12.5, 18.4) 16.9 (14.8, 19.2)
 Miami 4,054 28.8 (25.0, 33.0) 30.8 (26.8, 35.2) 28.8 (24.8, 33.3) 31.5 (27.0, 36.4)
 san diego 4,066 31.2 (27.1, 35.6) 33.3 (28.6, 38.4) 37.8 (32.5, 43.5) 21.8 (18.8, 25.1)
notes: aSupplement users were defined as users by either the medication inventory or the dietary supplement interview. Categories presented for comparison of 
distributions include only users of any dietary supplement, users of primarily nvnM products (including botanicals), and users of botanical supplements (including 
fiber). bN, number of participants in sample, rather than the representative population. cMeans and percentages reflect sample weights and are age standardized to 
the Us population. dPhysical activity data were summarized as meeting or not meeting cdc 2008 guidelines for physical activity. enutritional data were summarized 
with the alternative healthy eating Index-2010 (aheI-2010). the aheI was developed to update prior healthy eating indices based on Us dietary guidelines with 
recommendations derived from scientific studies of diet and health outcomes.33,34 the aheI assigns values for consumption of vegetables, fruit, whole grains, 
sugar-sweetened beverages, nuts/legumes, red/processed meats, trans fat, long-chain n-3 fatty acids, total polyunsaturated fatty acids, sodium, and alcohol intake 
with a maximum value of 110.34 healthy individuals aged 55–80 in the nurses’ health study had a mean aheI-2010 of 53.2.33
Abbreviation: aheI, alternative healthy eating index. 
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– including all fiber products as botanicals, a reasonable, but 
not universal assumption, markedly increased estimates, as 
did the inclusion of botanical teas and other liquid dietary 
supplements ascertained in the 24-hour dietary recall files.
comparability of assessment comparisons. The most 
accurate self-report measure of dietary supplement use is 
considered to be a detailed interview with label capture and 
transcriptions, conducted in the home.12 Other studies have 
used a label capture system conducted in the clinic for sup-
plement assessment, similar to the medication inventory in 
HCHS/SOL.20,21 In these studies, participants completed a 
dietary supplement questionnaire at home prior to the in-per-
son interview, perhaps prompting improved supplement recall.
Kappa statistics in studies comparing questionnaires with 
label capture have been variable, ranging from 0.46 to 0.92.12,21 
Agreement of supplement use as measured by a telephone 
interview compared to a label capture was somewhat lower–
with a kappa as low as 0.14.20 A fourth study compared vita-
min and mineral supplement assessment via a self-completed 
health questionnaire and two types of dietary assessments, 
a food frequency questionnaire and a 7-day food diary.22 
Agreement in these studies comparing the three instruments 
was substantial (κ: 0.72–0.81).
In contrast, our agreement statistics are somewhat lower, 
especially for botanical products. Although every effort was 
made to classify dietary supplement products similarly in the two 
datasets, some misclassification was likely, given the amount of 
missing information in the medication inventory. In addition, 
a kappa statistic is less reliable in a setting of low prevalence, 
as seen with botanical supplements23 and with imbalances 
in the marginal totals as was seen in both the botanical and 
NVNM data.24 However, moderate agreement was seen with 
the comparisons of overall dietary supplement use and with 
the comparisons of NVNM supplements and negative agree-
ment statistics were uniformly high.
35.0%
30.0%
25.0%
20.2%
27.8%
31.6%
17.0%
21.6%
23.9%
6.6%
15.34%
20.3%
4.7%
0.9%
8.4%
11.3%
2.7%
4.8% 4.8%
9.7%
12.9%
20.0%
15.0%
10.0%
5.0%
0.0%
NVNM (female) NVNM (male)
DI, no recall, no nopal DI, with recall, no nopal DI, with recall, with nopal
Botanical (female) Botanical (male) Liquid Powder
figure 2. Prevalence of nvnM supplements considering the addition of supplements captured in the dietary recalls. Prevalence estimates are 
standardized to the 2010 US Census and weighted with sample and nonresponse weights and stratified by gender: ‘DI no recall no nopal’ references the 
dietary supplement interview data without dietary recall data. “dI with recall no nopal” references the dietary supplement interview data with the addition 
of dietary recall data, but excluding raw nopal and green tea. “dI with recall with nopal” references the dietary supplement interview data with dietary 
recall data, including raw/cooked nopal and green tea.
note: Only nopal ingested outside recipes were included in these estimates.
supplements, while lutein and lycopene were often added to 
multivitamin products. Other common combination products 
included those containing glucosamine (3.4%) and lipotropic 
agents (primarily lecithin and inositol –3.4%).
Many combination products containing vegetable or 
fruit extracts were counted as botanicals. Over 2% of study 
participants consumed a supplement with at least one vegetable 
extract and over 4% consumed a product containing a fruit 
extract. Culinary herbs, such as parsley, sage, and oregano 
were occasional constituents of combination products.
Ginkgo and ginseng were the most commonly reported 
botanicals (2.6%), followed by green tea extracts and garlic 
(1.7%). Licorice was also a component of botanical products 
among about 1% of participants. Chamomile at 0.23% and 
nopal at 0.13% were less common constituents of dietary sup-
plement products – almost 2% of participants reported con-
suming chamomile tea in the dietary recall (1.9%; 95% CI: 
1.6–2.3).
discussion
Depending on the assessment (medication inventory and/or 
dietary supplement interview ± dietary recall data), HCHS/
SOL estimated that 4.5%–19% of participants reported tak-
ing botanical supplements and 12%–32% reported use of 
NVNM supplements, including botanicals. Results of this 
study demonstrate the challenges of accurate dietary supple-
ment assessments, particularly with regard to the botanical 
and other NVNM products. Estimates based on the medica-
tion inventory alone differed substantially from those based 
on the dietary supplement interview and neither assessment 
appears to have captured the use completely. Some products 
were reported only with the medication inventory and the 
others only with the dietary supplement interview. Botani-
cal estimates in particular were markedly sensitive to vary-
ing assumptions about what constitutes a botanical product 
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table 3. Prevalence of selected supplement ingredients in the 30-day dietary supplement interview in hchs/sOL.
SUppLeMent 
IngReDIent
n pRevALenCe SUppLeMent 
IngReDIent
n pRevALenCe
vitamins 5,674 32.7 (31.5, 33.9)
Minerals 5,484 31.7 (30.4, 33.0) garlic 333 1.7 (1.4, 2.1)
nvnM ginger 111 0.65 (0.49, 0.87)
amino acids 562 3.1 (2.8, 3.6) ginkgo 454 2.6 (2.2, 3.0)
chondroitin 351 1.9 (1.6, 2.3) ginseng 435 2.6 (2.3, 3.0)
coenzyme Q10 158 1.0 (0.7, 1.3) graine 271 1.5 (1.3, 1.8)
collagen 179 0.9 (0.7, 1.1) grape seed 176 0.90 (0.72, 1.1)
enzyme 55 0.25 (0.18, 0.36) green tea 277 1.7 (1.4, 2.0)
Fiber 246 1.3 (1.1, 1.5) guarana 54 0.29 (0.20, 0.41)
glucosamine 664 3.4 (3.0, 4.0) hawthorn 42 0.21 (0.13, 0.34)
Lipotropica 666 3.4 (3.1, 3.8) holy basil (tulsi) 29 0.21 (0.11, 0.38)
Lutein 1,574 9.5 (8.8, 10.3) horseradish 53 0.37 (0.24, 0.58)
Lycopene 1,654 10.5 (9.7, 11.4) horsetail 160 0.70 (0.54, 0.90)
MsM 271 1.4 (1.1, 1.7) Licorice 232 0.93 (0.77, 1.1)
Omega-3b 1,765 9.6 (9.0, 10.4) Milk thistle 71 0.50 (0.30, 0.84)
Omega-6c 190 1.1 (0.83, 1.4) Mint 54 0.27 (0.19, 0.38)
Omega-9d 143 0.87 (0.62, 1.2) Mushroom 102 0.43 (0.30, 0.63)
Probiotics 120 0.55(0.42, 0.72) nettle 45 0.37 (0.21, 0.65)
Protein 359 2.2 (1.8, 2.6) Olive leaf 40 0.20 (0.13, 0.32)
Botanicals Parsley 153 0.88 (0.69, 1.1)
aloe 127 0.60 (0.45, 0.79) Pepper (black) 43 0.23 (0.11, 0.40)
astragalus 48 0.29 (0.18, 0.48) Pine bark 93 0.39 (0.29, 0.53)
Bioflavonoids 36 0.28 (0.17, 0.46) Pumpkin seed 59 0.48 (0.31, 0.73)
Black cohosh 80 0.30 (0.22, 0.40) rhodiola 88 0.40 (0.29, 0.56)
Boswellia 81 0.27 (0.19, 0.37) rose hips 75 0.29 (0.21, 0.40)
cascara/senna 61 0.30 (0.22, 0.42) rosemary 94 0.57 (0.42, 0.77)
cayenne 96 0.41 (0.31, 0.54) sage 37 0.21 (0.12, 0.36)
cinnamon 101 0.48 (0.36, 0.64) saw palmetto 106 0.88 (0.66, 1.2)
chamomile 54 0.23 (0.16, 0.33) schisandra 59 0.35 (0.24, 0.50)
dandelion 75 0.38 (0.27, 0.53) seaweed 213 1.0 (0.82, 1.3)
dong quai 52 0.22 (0.15, 0.33) soy 100 0.49 (0.37, 0.64)
echinacea 101 0.69 (0.52, 0.92) spirulina 157 0.86 (0.67, 1.1)
elderberry 52 0.33 (0.21, 0.52) turmeric 79 0.37 (0.26, 0.53)
eleuthero 103 0.55 (0.38, 0.81) valerian 44 0.22 (0.15, 0.31)
Fennel 54 0.28 (0.20, 0.40) vegetable extract 432 2.3 (2.0, 2.7)
Fo-ti 58 0.21 (0.15, 0.30) Yerba Mate 40 0.25 (0.17, 0.37)
Fruit extracts 796 4.1 (3.7, 4.5)
notes: chamomile, green tea, and nopal are also commonly consumed as foods – not included in these estimates. Prevalence estimates are based on the entire 
sample rather than within dietary supplement users and are adjusted for age and the complex survey weights. aLipotropic: lecithin, inositol. bOmega-3: fish oils, 
flaxseed oil; cOmega-6: linoleic acid, borage, evening primrose oils; dOmega-9: olive oil, oleic acid; egrain: oats, wheat, corn, quinoa, alfalfa.
Low agreement was not surprising, given the very different 
supplement ascertainment by the two systems. A review of 
medications is more likely to underestimate dietary supple-
ment use. In clinical situations, accurate capture of dietary 
supplement use is uncommon: 33% of individuals with chronic 
disease reported that they had informed their healthcare 
provider of their supplement use and disclosure rates were 
lower among Hispanics (22%).13 When asked why they did not 
disclose their supplement use, patients reported that they did 
not think that it was important for their providers to know.25 
A similar mechanism may be driving the lower prevalence in 
the medication inventory data in this study.
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On the other hand, the dietary supplement interview 
benefited from both a systematic inquiry and the use of 
DSAM, a detailed database designed specifically for the 
capture of dietary supplement data. In addition, the dietary 
supplement interview followed a detailed interview about food 
intakes in the past 24 hours. Individuals may have been more 
likely to recall supplements they regarded as enhancements to 
their diet after a 24-hour dietary recall.
The value of the medication inventory and the dietary 
supplement interview independently could be called into ques-
tion. However, together, and when combined with data from 
the 24-hour dietary recalls, a more complete picture of supple-
ment use emerges. Comparisons of supplement assessments by 
these different techniques furnish important information about 
the impact of study design on reports of supplement prevalence 
in the Hispanic/Latino literature. Wide variations in botanical 
supplement prevalence may result from differences in assess-
ment strategies as well as supplement definitions (including vs 
excluding botanical teas). In addition, because of the high prob-
ability of under-reporting, asking about supplement use multi-
ple times is more likely to yield accurate estimates. In a study of 
home remedies for childhood diarrhea, researchers only learned 
of the botanical remedies after establishing a trusted relation-
ship with participants.26
comparing HcHs/soL dietary supplement preva-
lence estimates to other studies. Depending on the instrument 
(inventory vs interview), HCHS/SOL prevalence estimates of 
botanical dietary supplement use in the last 30 days ranged from 
4.5% to 9%, increasing to 15% with the addition of data from 
the dietary recall (botanical teas and other liquid supplements 
also consumed as foods). Commonly reported supplements 
were consistent with patterns in the general US public, rather 
than those reportedly common among Hispanics/Latinos 
such as aloe, mint, chamomile, flax, and linden.27 Interestingly, 
botanicals traditional among Hispanics/Latinos were more 
often reported with the 24-hour dietary recalls than with either 
the dietary supplement interview or the medication inventory.
Comparable studies were limited to four; most of them 
targeted an older population. In a home-based interview of 
dietary supplement use in the past two weeks with label cap-
ture among individuals aged $77 years in Texas, about 38% of 
Hispanics reported using vitamin or mineral supplements and 
5% reported using botanicals, most commonly garlic, ginkgo, 
and saw palmetto.28 Another study employed a similar strat-
egy (home-based interviews, use in the past two weeks) among 
Mexican Americans aged $65 years across the US–Mexican 
Border States and reported botanical medicine use was about 
10%.29 In this latter study, investigators specifically inquired 
about the use of herbal teas and the most common botani-
cal supplements were consistent with the previously reported 
favorites among Hispanics/Latinos: chamomile, mint, and 
aloe.29 In another study, using a telephone interview of sup-
plement and medication use in the past seven days30 in the 
general US public, the prevalence of NVNM use was 12% 
among Hispanics; the most common supplements were lutein, 
ginkgo, garlic, and glucosamine,30 similar to those reported 
in HCHS/SOL. Another telephone interview (subjects $52) 
reported Hispanic/Latino use of any supplement at 45% and 
botanicals at 12%.
Limitations and strengths. All HCHS/SOL participants 
were recruited from urban centers; the dietary supplement 
habits of Hispanics/Latinos in rural areas may be very different. 
However, although the target population is limited to the four 
cities, HCHS/SOL’s design, using probability sampling within 
diverse regions, is superior to the convenience samples typical 
of many dietary supplement studies in these populations.
Dietary supplement assessment suffers from the same lim-
itations as other data largely dependent on self-report or inven-
tory methods conducted outside the home. It is unlikely that 
the medication inventory or the dietary supplement interview 
alone adequately captured supplement use. In the medication 
inventory, because supplements were spread across the files, 
instead of receiving a designation as a supplement, some supple-
ments could have been missed, artificially reducing the preva-
lence estimates resulting from these data. On the other hand, 
the dietary supplement interview could have been improved by 
the use of prompts for supplements common among Hispanics/
Latinos (eg, chamomile, mint, and aloe) rather than those com-
mon in the general population (Echinacea, ginseng, ginkgo, 
St. John’s wort). However, the dietary supplement interview 
data, using the DSAM, achieved much greater detail than has 
been reported in prior studies.  The ability to add botanical teas 
from the 24-hour dietary recall data filled in some of the miss-
ing information from the dietary supplement interview alone. 
Moreover, the combination of instruments enriched the picture 
of dietary supplement use in the population.
An additional limitation of self-reported data is that con-
sistency of use is impossible to determine. This limitation also 
applies to administrative data: even with prescription fill data, 
it is unclear whether or not individuals are taking the medica-
tions they purchase.
Public health significance. The importance of accurate 
measurement of dietary supplement use cannot be overstated. 
Although dietary supplements have biologic activity with the 
potential for adverse reactions and interactions with drugs,31,32 
dietary supplements are not regulated with the same level of 
scrutiny as drugs.31,33 The limited regulation also precludes 
adequate surveillance of use – estimates of interactions and 
harmful reactions rely on adverse events reporting from indi-
vidual users and their healthcare providers, many of which 
will go unrecognized.1,34 Unlike prescription drugs, track-
ing use via pharmacy charges is not possible, and supplement 
recording via medical records is poor,35 particularly among 
ethnic minorities.36 In an era of electronic health records, 
an updated, user-friendly dietary supplement database could 
greatly enhance the ability of clinicians to capture supple-
ment use among patients, perhaps even by enabling patients to 
input their own supplement and over-the-counter products.
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Areas for future research. The reported prevalence of 
types of dietary supplements (botanical, NVNM) has been 
variable among Hispanics/Latinos. Some of this variability is 
related to sampling design (probability vs convenience), but, 
based on the findings in this report, it is likely that some of 
the variability reflects the nonstandardized definitions of what 
constitutes a botanical or even a dietary supplement. Studies 
that include only purchased dietary supplement products are 
not counting home remedies such as botanical teas. Because 
unprocessed botanicals and teas are part of the health practices 
of many ethnic minority populations, including Hispanics/
Latinos, excluding them from estimates may seriously under-
estimate use. In addition, failing to inquire about the use of a 
wide range of dietary supplements, including botanical teas, 
compromises clinical assessments. Development of dietary 
supplement assessment strategies that are rapid, patient- 
and provider-friendly, and comprehensive are likely to both 
enhance patient empowerment and increase patient safety.
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